Lv1
50 积分 2025-08-28 加入
Lobe-Specific Lymph Node Dissection May be Feasible for Clinical N0 Solid-Predominant Part-Solid Lung Adenocarcinoma With Solid Component Diameter ≤ 2 cm
6个月前
已完结
Preoperative Prognosis Prediction for Pathological Stage IA Lung Adenocarcinoma: 3D-Based Consolidation Tumor Ratio is Superior to 2D-Based Consolidation Tumor Ratio
6个月前
已完结
Early Compliance with Lung Cancer Lymph Node Standard 5.8: An Analysis of 2022 and 2023 Commission on Cancer Site Reviews
7个月前
已完结
Tumor-draining lymph nodes: At the crossroads of metastasis and immunity
7个月前
已完结
Omitting Lymph Node Dissection for Small Ground-Glass Opacity–Dominant Tumors
7个月前
已完结
Preoperative Prognosis Prediction for Pathological Stage IA Lung Adenocarcinoma: 3D-Based Consolidation Tumor Ratio is Superior to 2D-Based Consolidation Tumor Ratio
7个月前
已完结
Preoperative Prognosis Prediction for Pathological Stage IA Lung Adenocarcinoma: 3D-Based Consolidation Tumor Ratio is Superior to 2D-Based Consolidation Tumor Ratio
7个月前
已完结
Phase III Study of Mediastinal Lymph Node Dissection for Ground Glass Opacity-Dominant Lung Adenocarcinoma
7个月前
已完结
From knowledge to action: The journey toward targeting the MET pathway via MET exon 14 skipping
7个月前
已完结
MET Alterations in Cancer and MET-Targeted Therapy: Detection Strategies, Treatment Efficacy, and Emerging Technologies
7个月前
已完结
皖公网安备34019202002308
